Showing results (51-60 of 121) with videos related to
Sort By:
Pageof 13
Lakartidningen|December 7, 2000
[High-dose melphalan with stem cell support is now an established myeloma therapy. Treatment of myeloma from a 30-year perspective]M Hjorth, S Lenhoff, I Turesson, et al.Clinical and Experimental Immunology|August 1, 1979
An IgM monoclonal protein with multiple serological specificitiesG Merlini, A Forsgren, I Turesson, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Bone cell viability after irradiation. An enzyme histochemical studyM Jacobsson, P Kälebo, A Tjellström, et al.Acta Medica Scandinavica|January 1, 1980
Predominant B-lymphocyte deficiency in a case with lymph node disease resembling angioimmunoblastic lymphadenopathyB Persson, A Rausing, I Turesson, et al.Acta Oncologica (Stockholm, Sweden)|January 1, 1987
Bone healing following irradiation during tourniquet ischaemiaP Kälebo, M Jacobsson, T Albrektsson, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Evidence for individual differences in the radiosensitivity of human skinS L Tucker, I Turesson, H D ThamesRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1990
Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy: a graded-response analysisS M Bentzen, I Turesson, H D ThamesInternational Journal of Radiation Oncology, Biology, Physics|November 1, 1985
Dose-response for bone regeneration after single doses of 60Co irradiationM Jacobsson, A Jönsson, T Albrektsson, et al.Blood|June 11, 1999
Serum hyaluronan in patients with multiple myeloma: correlation with survival and Ig concentrationI M Dahl, I Turesson, E Holmberg, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
Expression of protein HC on the plasma membrane of different human cell typesE Pearlstein, I Turesson, L Tejler, et al.Pageof 13